Skip to content

The global life sciences industry is evolving at an extraordinary rate. These changes give rise to a host of complex legal and regulatory issues impacting both life sciences companies and their financial backers.

Sidley’s Global Life Sciences group looks at 12 forces driving the life sciences legal and regulatory landscape in 2022, and provides practical tips on a range of topics for life sciences companies and investors seeking to navigate through, and capitalize on, this complex environment.

For ease of viewing, you may choose to view the full report or click on the tabs below to navigate to specific areas of interest.